-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H/QPmokVYXvaeGKptWVz6FS97wt7xpmM9BfuqULrX87bdWkk1U18dAhCIH9Yo7CX wKZMUUAfjhHVAL4IL9fzmA== 0000875320-06-000087.txt : 20061024 0000875320-06-000087.hdr.sgml : 20061024 20061024125842 ACCESSION NUMBER: 0000875320-06-000087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061023 FILED AS OF DATE: 20061024 DATE AS OF CHANGE: 20061024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH IAN F CENTRAL INDEX KEY: 0001197032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 061159596 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-10-23 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197032 SMITH IAN F C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 0 1 0 0 EVP & CFO Common Stock 2006-10-23 4 M 0 1607 15.87 A 82617 D Common Stock 2006-10-23 4 M 0 2213 15.60 A 84830 D Common Stock 2006-10-23 4 S 0 3820 33.65 D 81010 D Common Stock 4302 I shares 401(k) Stock Option 15.87 2006-10-23 4 M 0 1607 0 D 2002-10-22 2012-07-21 Common Stock 1607 339598 D Stock Option 15.60 2006-10-23 4 M 0 2213 0 D 2003-04-18 2013-01-17 Common Stock 2213 337385 D Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 7/22/2002. Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 1/18/2003. Valerie L. Andrews, Attorney-In-Fact 2006-10-24 -----END PRIVACY-ENHANCED MESSAGE-----